64.4% of IBD patient suffers
from ULCERATIVE COLITIS & 25.3%
suffers from CROHN'S DISEASE
Mesalazine Sustained Release Pellets 2gm Sachet
- Effective in inducing and maintaining remission in ulcerative colitis by reducing inflammation in the colon.
- Effectively treats mild to moderate Crohn's Disease.
- Equally as effective as a standard dosage of steroids in the treatment of the mild to moderate form of Crohn's ileitis.
- Reduces the risk of neoplastic progression in chronic ulcerative colitis.
